c Burkholderia cenocepacia is the most prevalent and feared member of the Burkholderia cepacia complex in lung infections of cystic fibrosis (CF). Genotyping and monitoring of long-term colonization are critical at clinical units; however, the differentiation of specific lineages performed by multilocus sequence typing (MLST) is still limited to a small number of isolates due to the high cost and time-consuming procedure. The aim of this study was to optimize a protocol (the SNaPBcen assay) for extensive bacterial population studies. The strategy used for the SNaPBcen assay is based on targeting single nucleotide polymorphisms (SNPs) located in MLST genes instead of sequencing full MLST sequences. Nonpolymorphic and redundant MLST positions were eliminated, and a set of 24 polymorphisms included in the SNaPBcen assay ensures a high-resolution genomic characterization. These polymorphisms were identified based on the comparative analysis of 137 B. cenocepacia MLST profiles available online (http://pubmlst.org/bcc/). The group of 81 clinical isolates of B. cenocepacia examined in this study using the SNaPBcen assay revealed 51 distinct profiles, and a final discriminatory power of 0.9997 compared with MLST was determined. The SNaPBcen assay was able to reveal isolates with microvariations and the presence of multiple clonal variants in patients chronically colonized with B. cenocepacia. Main phylogenetic subgroups IIIA, IIIB, and IIIC of B. cenocepacia could be separated by the Gl94R polymorphism included in the panel. The SNaPBcen assay proved to be a rapid and robust alternative to the standard MLST for B. cenocepacia, allowing the simultaneous analysis of multiple polymorphisms following amplification and mini-sequencing reactions.
T
he Burkholderia cepacia complex (Bcc) includes Gram-negative ubiquitous bacteria characterized by fabulous metabolic versatility that facilitates adaptation to a wide range of milieus. The Bcc comprises at least 17 closely related species (1, 2) frequently studied for biological control of plant and animal pathogens, bioremediation of recalcitrant xenobiotics, and plant growth promotion (3) . Nevertheless, Bcc bacteria have been associated with a variety of human infections, particularly in cystic fibrosis (CF) patients (4) . Once acquired, B. cenocepacia is rarely eradicated from the CF airways by antibiotic therapy due to its intrinsic resistance to antibiotics and other adverse and stressful conditions to which they are exposed in the CF lung (5) . B. cenocepacia can be responsible for highly transmissible infections among individuals (6) . Long-term respiratory infections with B. cenocepacia are particularly threatening because they generally lead to a more rapid decline in lung function and may cause the fatal cepacia syndrome (4, 7) .
In the last decades, several methods have been used for molecular identification and genotyping of Bcc species, particularly B. cenocepacia, based on the amplification of single or multiple target sequences. Multilocus enzyme electrophoresis (MLEE) characterizes allelic variation by electrophoretic mobility in sets of randomly selected housekeeping genes, delineating families of strains typical of geographic and regional populations (8) ; multilocus restriction typing (MLRT) analyses the variations of several loci by amplification of target genes, which allow an assessment of relatedness between distinct clonal lineages (9) . However, these methods are not as portable and reproducible as multilocus sequence typing (MLST). MLST facilitates the discrimination of microbial isolates by comparing the sequences of seven housekeeping gene fragments (10) . MLST showed a discriminatory power above the 0.97 value for Bcc being used in studies concerning microbial population structure and evolution, for evaluation of genetic variation, in the identification of infection sources and outbreaks, and for definition of extensive and endemic microbial populations (11) (12) (13) . MLST is more effective than MLEE and MLRT for the detection of clonal relatedness, presenting a limited competence for recognition of recombination events (14) . Currently, the MLST profiles of more than 700 Bcc strains or isolates are freely available online (http://pubmlst.org/bcc/), facilitating the comparison and transference of data between laboratories. Nevertheless, MLST is still applicable to a limited number of isolates due to the associated costs and duration of the full procedure. Hence, it is necessary to develop alternative methods able to facilitate such studies and to boost bacterial genotyping by allowing large-scale analysis.
Single nucleotide polymorphism (SNP)-based methods have been purposed to identify species and differentiate specific lineages for a few bacteria (15) (16) (17) . SNP multiplex assays are practical and sensitive methodologies for simultaneous analysis of several polymorphisms (18) . The method consists of a first multiplex PCR that amplifies target genomic regions containing the polymorphisms, which are subsequently detected by mini-sequencing. The mini-sequencing is performed using single base extension primers and fluorescently labeled dideoxy nucleoside triphosphates (ddNTPs). By employing primers with different lengths (nucleotide tails can be added at 5=), this practice allows the recognition of fragments of multiple sizes by automated capillary electrophoresis. The results appear as a plot with different colored peaks that represent site-specific genomic variations. A previous study already proposed a SNP multiplex assay for identification of some Bcc species by targeting six polymorphisms in the gyrB gene (16) . However, the differentiation of specific lineages is still performed by MLST. A SNP-based strategy has recently been developed for genotyping of Pseudomonas aeruginosa, presenting a discriminatory power of 0.9993 in comparison with MLST (19) .
Thus, aiming to optimize a method able to overcome the limitations of MLST to identify lineages and genotype large number of bacterial isolates, in the present work we developed a SNPbased method for genotyping B. cenocepacia, here designated the SNaPBcen assay. B. cenocepacia is the most clinically relevant species within the complex; therefore, it was the focus of the present study. The standard MLST method for Bcc required the sequencing analysis of 2,377 nucleotides, but only some of these positions present relevant genotyping information. Nonpolymorphic positions, as well as redundant polymorphic positions, were eliminated. Finally, the method targeted a set of 24 polymorphisms located in six MLST genes and the assortment of the most informative nucleotide positions allowed a high-resolution genomic characterization of bacterial isolates. Thus, the proposed method represents a practical approach for genotyping the isolates of B. cenocepacia, allowing extensive microbial population studies and monitoring of long-term colonization.
MATERIALS AND METHODS
B. cenocepacia isolates and DNA extraction. Eighty-one isolates of B. cenocepacia recA lineages IIIA and IIIB, obtained at both the Portuguese CF Treatment Center at Santa Maria Hospital (HSM) in Lisbon and Hospital S. João in Oporto, were used in this study (see Table S1 in the supplemental material). The HSM isolates were obtained during the past 18 years, as part of the hospital routine, from respiratory secretions of CF patients and were characterized molecularly and phenotypically at the IBB/IST laboratory (20) (21) (22) (23) (24) . A small group of non-cenocepacia species of the Bcc, B. cepacia (n ϭ 10), B. contaminans (n ϭ 5), B. dolosa (n ϭ 6), B. multivorans (n ϭ 5), and B. stabilis (n ϭ 4), was also included in the present study. B. cenocepacia isolates and other bacterial isolates were kept frozen at Ϫ80°C and cultured on Pseudomonas isolation agar (Difco) medium plates before DNA extraction. Single colonies of each isolate were suspended in 4 ml of Luria-Bertani broth (Difco) medium and grown overnight with orbital agitation (250 rpm) at 37°C. Total genomic DNA was extracted from B. cenocepacia isolates, using a cell and tissue kit (Gentra Systems; Qiagen). The concentrations of genomic DNA solutions and quality parameters (260/280 nm and 260/230 nm) were estimated using an ND-1000 Spectrophotometer (NanoDrop). Finally, two DNA purification steps performed with ethanol (70 [vol/vol]) were added to the protocol. Bacterial DNA was finally suspended in 50 l of ultrapure water and stored at Ϫ20°C.
MLST genotyping and sequencing analysis. Seven fragments of housekeeping genes (atpD, gltB, gyrB, recA, lepA, phaC, and trpB) used for MLST were amplified in B. cenocepacia and non-cenocepacia isolates (10) . The suggested primers were employed, and new primers were designed for cases with amplification problems employing Primer3 (v0.4.0; http://frodo.wi.mit.edu/) (25) . Subsequently, hairpin and primer-dimer secondary structures were avoided by using AutoDimer v1 (http://www.cstl.nist.gov/biotech/strbase/AutoDimer Homepage/AutoDimerProgramHomepage.htm) (26) . The final set of primers employed for amplification of MLST gene fragments is shown in Table S2 in the supplemental material. Touchdown PCR was conducted using a final volume of 5.0 l, containing 2.5 l of multiplex PCR master mix (Qiagen), 0.5 l of bacterial DNA (50 to 250 ng), 0.5 l of primer mix (each one at 2 M), 0.5 l of Q-solution (Qiagen), and 1.0 l of ultrapure water. PCR conditions were as follows: denaturation for 15 min at 95°C; 26 cycles with denaturation for 1 min at 95°C, primer annealing for 30 s at 57°C (recA), 60°C (atpD, gltB, lepA, phaC, and trpB), or 64°C (gyrB), and extension for 2 min at 72°C; and final extension for 10 min at 72°C. Before the primer annealing, touchdown PCR with three successive cycles (total of nine cycles) at increasing temperatures was performed. Finally, amplicon sizes were confirmed after separation by polyacrylamide gel electrophoresis and standard silver-staining detection (27) .
PCR fragments were purified with ExoSap-IT (Escherichia coli exonuclease I and shrimp alkaline phosphatase; USB Corporation), according to the manufacturer's instructions. Sequencing reactions were carried out using an ABI BigDye Terminator cycle sequencing ready reaction kit (Applied Biosystems). The sequencing reactions included an incubation for 2 min at 96°C followed by 35 cycles with denaturation for 15 s at 96°C, primer annealing for 9 s at 50°C, extension for 2 min at 60°C, and then 10 min at 60°C. The product was purified using Sephadex (Expansys) columns and a volume of 8.0 l HiDi formamide (Applied Biosystems) added to the product before sequencing analysis on an ABI Prism 3100 genetic analyzer (Applied Biosystems).
SNaPBcen assay. The strategy used for the SNaPBcen assay is based on targeting SNPs located in MLST genes instead of sequencing full MLST sequences. A nonhomologous tail was added at the 5= end of extension primers to allow the separation by capillary electrophoresis. The final size of each primer plus the nonhomologous tail ranged from 17 to 116 bp (Table 1) . In silico prevention of hairpin and primer-dimer secondary structures was performed by using AutoDimer v1. The SNaPBcen assay was carried out in a final volume of 5 l, containing 1.5 l of PCR product (purified with ExoSap-IT as described above), 1 l of SNaPBcen primer mix (each one at 1 M), 1 l of ABI Prism SNaPshot multiplex kit (Applied Biosystems), and 1.5 l of ultrapure water. The reaction mixture was run with 25 extension cycles under the following conditions: denaturation for 10 s at 96°C, primer annealing for 5 s at 50°C, and extension for 30 s at 60°C. Unincorporated ddNTPs were removed with 1 U of SAP (shrimp alkaline phosphatase; USB Corporation) following incubation for 1 h at 37°C and 15 min at 85°C as suggested by the manufacturer. SNaPBcen products (0.5 l) were mixed with 9.0 l of HiDi formamide and 0.5 l of GeneScan-120 LIZ size standard (Applied Biosystems). Electrophoresis was performed on a 3130xl Genetic Analyzer (Applied Biosystems) using the filter set E5, and the data were analyzed with the software GeneMapper v4.0 (Applied Biosystems).
Data and statistical analysis. The MLST profiles of 137 online entries of B. cenocepacia (downloaded from http://pubmlst.org/bcc/) were deposited in an in-house record that included the MLST data of bacteria sequenced in this study. Network analysis was performed with the Network 4.6.1.0 program (www.fluxus-engineering.com/sharenet.htm) (28) . Procedures to determine minimum spanning trees were performed at the MLST website (http://pubmlst.org/perl/mlstanalyse/mlstanalyse.pl?site ϭpubmlst&pageϭmst&refererϭpubmlst.org). Statistical analysis was performed using Arlequin 3.1 software (http://cmpg.unibe.ch/software /arlequin3/) (29) and Microsoft Office Excel 2010 (Microsoft Corporation). Simpson's diversity index was applied to determine the discriminatory power of individual SNPs and of the proposed multiplex strategy.
genotyping strategy for Bcc based on singleplex amplification of seven housekeeping genes were revealed to be inadequate to the newly proposed multiplex amplification that included the genes atpD, gltB, lepA, phaC, and trpB due to lower melting temperatures and to the formation of dimers and several unspecific bands. The genes gyrB and recA were amplified in singleplex. Therefore, new primers were designed for B. cenocepacia employing Primer3 software (see Table S2 in the supplemental material) and alternative touchdown PCR conditions proposed for the amplification of MLST fragments as described in Materials and Methods. The newly designed genotyping protocol was highly reproducible and enabled mini-sequencing analysis of the MLST gene fragments. The result of MLST amplification in a few isolates of B. cenocepacia is shown in Fig. 1 .
Selection of polymorphisms included in the SNaPBcen assay. For SNP selection, B. cenocepacia MLST sequences available online (at http://pubmlst.org/bcc/) were downloaded and concatenated to an in-house record that included the genomic data of B. cenocepacia strains from our collection. Key polymorphic positions located at MLST genes were selected based on the ability of the assay to discriminate B. cenocepacia strains and clonal variants. Nonpolymorphic and redundant positions were discarded. In addition, a few positions difficult to characterize on MLST sequences were also excluded. A last group of polymorphisms were removed due to difficulties in the design of primers targeting those positions. A final group of 24 polymorphisms were selected, representing 0.008% of the total number of nucleotides of the sequences targeted by standard MLST. However, a few sequence types (22 of 148 sequence types) described at the MLST online database, particularly some pairs of closely related sequence types (see complete list in Table S3 in the supplemental material), could not be differentiated based on the set of 24 selected polymorphisms. The group of 24 polymorphisms represented a theoretical discrimination of more than 15 billion genotypes, which guaranteed a high diversity of profiles in B. cenocepacia (see Table 1 for the discriminatory power of each selected position). By comparing with the reference MLST and the complete list of strains (n ϭ 440) available online at MLST database, a discriminatory power (Simpson's diversity index) of 0.9997 was described for the SNaPBcen markers. Therefore, the SNaPBcen assay presented a discriminatory power similar to that of MLST.
The SNaPBcen assay was also tested in a group of non-cenocepacia isolates, but no more than 13 markers could be observed (data not shown); due to marker specificity for B. cenocepacia, the complete group of markers could be amplified only in B. cenocepacia isolates. SNaPBcen assay for genotyping of B. cenocepacia isolates. The SNaPBcen assay ensured an electrophoretic profile with 24 peaks for B. cenocepacia isolates distinguished by automated capillary electrophoresis (Fig. 2 ). The SNaP profile could then be obtained to facilitate comparison with MLST data, as shown in Fig. 2 . The assay was further tested in a group of 81 clinical isolates of B. cenocepacia (see Table S1 in the supplemental material), revealing 51 distinct SNaP profiles. Further sequencing of MLST genes in the group of isolates with similar SNaP profiles showed the absence of polymorphisms in 98% of the isolates-a single isolate could not be differentiated by the SNaPBcen assay. All clinical isolates with similar SNaP profiles corresponded to isolates collected from individual patients during several years of chronic infections; sequential isolates obtained from the same patient also showed the same recA RFLP profile and ribotype pattern (20, 22, 23) and had been considered clonal variants, presumably resulting from adaptive evolution in the CF lung during chronic infection (20) . No isolates with similar SNaP profiles were obtained from two distinct patients. Therefore, the proposed methodology was reproducible and able to distinguish the MLST profiles in our collection of B. cenocepacia. Figure 3 shows the distribution of the SNaP profiles observed in this study versus the SNaP profiles of the isolates collected worldwide whose MLST profiles are described in the MLST database. The collection of isolates experimentally tested in this study was not found grouped in the network far from the isolates previously reported worldwide; in fact, the genotypes were found dispersed along the network. A few isolates could be grouped according to genotyping similarity (G1 to G5 in Fig. 3 ) and corresponded to isolates with microevolutions or a few genetic differences in tested markers, most of the time obtained from the same patient. These cases were observed in previously characterized recA lineages IIIA and IIIB. The SNaPBcen assay was able to distinguish sequential clonal variants presenting a few genotyping differences retrieved from eight patients with long-term B. cenocepacia colonization (patients AB, AN, G, J, O, P, R, and T described in Table S1 in the supplemental material).
Occasionally, the patients were shown to be colonized simultaneously with two genetically very distinct strains, as in the case of patient O (Fig. 4) . Thirteen isolates obtained from patient O between 1998 and 2002 were included in this study and resulted in nine distinct SNaP profiles (four were characterized as IIIA and five as IIIB and are marked O_IIIA and O_IIIB, respectively, in Fig. 4 ). Isolates AB_A1, AB_A2, O_A1, and R_B1 showed additional mutations moving these isolates far from the groups AB, O_IIIA, and R; nevertheless, these isolates do have the same subgroup, recA RFLP profile, and ribopattern as all the patient group isolates. The SNaP profile of the isolate whose data are presented as described above was obtained according to Table 1 (e.g., At125F, At158R, . . ., Re195F) to facilitate comparison with MLST data. Markers are presented in alphabetic order; when markers (e.g., At158R) are amplified using reverse primers, the complementary base should be included in the SNaP profile.
phism Gl94R included in our panel, revealing a T, C, and G, respectively. The rare subgroup IIID was similar to IIIB in the marker Gl94R; however, it could be distinguished by combining markers At158R and Gy374R (IIID isolates presented A and G, respectively, while these positions never showed this profile in IIIB isolates). In silico analysis of the sequence types described at the MLST database agreed with this description. Therefore, the SNaPBcen assay could easily separate B. cenocepacia isolates of this study into the subgroups IIIA (n ϭ 41) and IIIB (n ϭ 40).
We analyzed a set of 137 unique online ST entries of B. cenocepacia isolates (obtained from pubMLST in November 2012) obtained from different countries between 1961 and 2012 plus the group of 51 SNaP profiles emerging from this study. SNaP profiles of isolates from Australia, the United States, Canada, and New Zealand were compared with the profiles in the complete group by network analysis and application of the minimum spanning tree method; similar subpopulations were selected for the temporal intervals 1961 to 1999 and 2000 to 2012. No subdivisions of isolates could be observed in either the spatial or temporal data sets, as previously described for the isolates of this study (see Fig. S1 and S2 in the supplemental material; minimum spanning trees resulted in similar distributions). Bacterial populations showed a global distribution along the networks, in concordance with the Garza-Williamson (G-W) index, which suggested nonbottleneck events (Table 1) .
DISCUSSION
The experimental strategy adopted in this study introduces an innovative methodology for genotyping B. cenocepacia based on the analysis of 24 SNPs located at the MLST genes. The SNaPBcen assay represents a practical and robust alternative to the standard MLST test used for B. cenocepacia, especially for large collections of isolates, allowing the simultaneous analysis of multiple polymorphisms following amplification and mini-sequencing reactions. This method uses neutral genetic polymorphisms which are important for understanding the diversity and dispersal mechanisms of this bacterium worldwide and could be used to improve the diagnosis and surveillance of B. cenocepacia in hospital laboratories. The newly proposed method can cost six to seven times less than MLST and produces genotyping results in few hours. SNaPBcen is a fast and reproducible assay and represents a valuable method for daily routine in clinical laboratories. A small number of alternatives are presently available for the genome analysis of Bcc species, especially of B. cenocepacia, most of them being not useful and reflecting a need for high-throughput molecular approaches for epidemiological analysis. In 2011, the analysis of 35 profiles of MLST suggested the reduction of the number of housekeeping genes from seven to six (by removal of lepA) in B. cenocepacia analyses to promote the cost-effectiveness of this strategy (31) . The assay proposed in the present study uses less than 0.008% of the total number of nucleotide sequences used in MLST in a single mini-sequencing reaction. The small number of polymorphisms tested with SNaPBcen considerably reduces the genotyping data analysis burden and the number of errors observed with some ambiguous MLST sequences. In addition, the present assay is able to differentiate the recA lineages IIIA, IIIB, IIIC, and IIID of B. cenocepacia. Remarkably, for this species only, among a group of isolates of different Bcc isolate species, the complete SNaP profile with 24 markers can be observed. The development of proper SNP genotyping panels for other Bcc species would also be advantageous for rapid analysis. Genotyping of B. cenocepacia may lastly become a low-cost test with all the subsequent benefits being valuable in cases of patients colonized or infected by multiple strains, as was the case of patient O reported in this study.
The analysis of our collection of isolates resulted in a set of SNaP profiles that showed no spatial or temporal subpopulations identified following network analyses, therefore corroborating the assumption of epidemic B. cenocepacia bacteria previously described as spreading within CF populations in Canada and Europe (4) . Several patients were found to be chronically colonized with the same B. cenocepacia clone, and the sequential isolates produced similar or closely related SNaP profiles. In fact, microvariation was frequently described in clinical Bcc isolates recovered sequentially from a CF patient during long-term infection, as previously reported (20, 21, 32) . These cases support the idea of the previously described plasticity of the B. cenocepacia genome with respect to accumulation of alterations and adaptation to a stressful pulmonary environment (33) . During chronic colonization, bacteria experience changing pressures exerted by the host environment, in particular, changes in nutrient availability, challenges of the immune defenses and antimicrobial therapy, and oxygen limitation (34) (35) (36) . These changes may lead to the emergence of phenotypic variants of the underlying clonal population (20, 24, (37) (38) (39) and decreased production of virulence factors associated with acute infections aiding immune evasion (35, 39, 40 noted in the present report that the emergence of B. cenocepacia clonal variant isolates showed several alterations in the SNaP profile during long-term infection and the progression of the disease. Rapid bacterial adaptation may be the consequence of antibiotic therapy or the presence of free radicals and/or the result of immune selective pressures (34) (35) (36) . This is not a new assumption, as an increasing mutation rate has been described in other bacteria under similar stressful conditions (39, (41) (42) (43) , but it supports the idea that this assay is suitable for differentiation of clonal variants with identical ribopatterns. Thus, the SNaPBcen assay is a powerful tool for definition of subgroups and genotyping B. cenocepacia strains, particularly for genotyping large collections of isolates. Furthermore, the flexibility of the method allows the modification and addition of extra markers in case they prove to be relevant for specific populations. This advantage may become very important, as progress in the generation of sequence data (44) can substantially increase the number of target polymorphisms useful for B. cenocepacia genotyping. An online SNP platform associated with the former and successful MLST database may complement and facilitate the analysis of the genotyping data available for this species. The SNaPBcen assay is suitable for rapid genetic analysis of large collections of B. cenocepacia isolates and employs limited resources and funds in comparison with the standard methods.
